Hartford Healthcare R3 HGHRX
At closeNov 3, 2026, 8:08 PM EST
Day range unavailable
- YTD
- +14.41%
- 1 year
- +20.46%
- EPS (ttm)
- 1.47
- P/E ratio
- 30.78
- YTD return
- +14.41%
- 1-year return
- +20.46%
- Previous close
- 45.08
- 52-week range
- 36.17 – 45.26
2Y +5.16 (+12.93%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 39.50
- 200-day average
- 40.18
About Hartford Healthcare R3
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of health care-related companies worldwide as selected by the sub-adviser, Wellington Management Company LLP ("Wellington Management"). The fund takes a broad approach to investing in the health care sector. It may invest in health-related companies, including companies in the pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services and emerging health-related subsectors.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on HGHRX — it syncs with the Stock Master app.